Li Bai

1989–2026 年に発表

430
論文数
19,964
被引用数
83
h 指数
269
i10 指数

被引用数

Li Bai の年別被引用数1998 年: 被引用 3 件1999 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 3 件2003 年: 被引用 6 件2004 年: 被引用 11 件2005 年: 被引用 25 件2006 年: 被引用 40 件2007 年: 被引用 76 件2008 年: 被引用 85 件2009 年: 被引用 139 件2010 年: 被引用 131 件2011 年: 被引用 211 件2012 年: 被引用 222 件2013 年: 被引用 198 件2014 年: 被引用 234 件2015 年: 被引用 268 件2016 年: 被引用 254 件2017 年: 被引用 273 件2018 年: 被引用 290 件2019 年: 被引用 569 件2020 年: 被引用 766 件2021 年: 被引用 839 件2022 年: 被引用 884 件2023 年: 被引用 728 件2024 年: 被引用 1,114 件2025 年: 被引用 633 件2026 年: 被引用 54 件

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 3,305 件、この内訳の 30.4%アメリカ合衆国: 引用元論文 1,602 件、この内訳の 14.7%イギリス: 引用元論文 613 件、この内訳の 5.6%ドイツ: 引用元論文 361 件、この内訳の 3.3%オーストラリア: 引用元論文 355 件、この内訳の 3.3%インド: 引用元論文 349 件、この内訳の 3.2%カナダ: 引用元論文 263 件、この内訳の 2.4%韓国: 引用元論文 244 件、この内訳の 2.3%フランス: 引用元論文 232 件、この内訳の 2.1%イタリア: 引用元論文 230 件、この内訳の 2.1%スペイン: 引用元論文 208 件、この内訳の 1.9%日本: 引用元論文 184 件、この内訳の 1.7%
0%30.4%その他 27%

分野

  • Medicine25.9%
  • Computer Science22.5%
  • Biochemistry, Genetics and Molecular Biology18.7%
  • Engineering7.9%
  • Immunology and Microbiology5.4%
  • Environmental Science4.9%
  • その他14.7%

トピック

  • Face and Expression Recognition3%
  • Face recognition and analysis2.3%
  • Immune Cell Function and Interaction1.6%
  • Cancer Immunotherapy and Biomarkers1.6%
  • Antibiotic Resistance in Bacteria1.5%
  • Inflammasome and immune disorders1.4%
  • その他88.6%

共著者

全論文

検索で開く
  1. Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ESCORT-1st Investigators, Xianglin Yuan, Dong Ma, Emily Liu, Feng Ye, Tianshu Liu, Xiuwen Wang, Likun Liu, Bing Xia, Fengming Ran, Sanyuan Sun, Zhanhui Miao, Jun Bie, Yong Gao, Junyan Yu, Li Chen, Yifu He, Wei Ren, Suxia Luo, Guangqiang Zhao, Youen Lin, Long Chen, Zhiyuan Guo, Chunhong Hu, Ying Wang, Nong Xu, Baofu Chen, Xianbao Zhan, Yuping Chen, Hongda Lu, Shukui Qin, Guolei Wang, Liming Chen, Li Bai, Jingdong Zhang - JAMA 2021 被引用: 801

  2. Membership Inference Attacks and Defenses in Federated Learning: A Survey

    著者: , , , , , - ACM Computing Surveys, ACM Comput. Surv. 2024 被引用: 89

  3. CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation

    著者: , , , , , , , , , , - Nature Communications 2017 被引用: 356

  4. Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xiu-Min Li, Fenghu Li, Sihai Liao, Qinghua Min, Lei Tang, Fei Shan, Jifang Gong, Yunong Gao, Jun Zhou, Zhihao Lü, Xiaofan Li, Jianjie Li, Hui Ren, Xiaohong Liu, Hongxia Yang, Wenting Li, Weifeng Song, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Xiaohua Wu, Jiafu Ji - The Lancet Oncology 2023 被引用: 197

  5. Expert consensus on the metaverse in medicine

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical eHealth 2022 被引用: 235

  6. Cosine Similarity Metric Learning for Face Verification

    著者: , - Lecture notes in computer science, ACCV (2) 2010 被引用: 665

  7. Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Changping Wu, Yang Zhang, Ping Yan, Chunlei Jin, Jianjun Zou - ˜The œLancet. Gastroenterology & hepatology 2021 被引用: 254

  8. GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair

    著者: , , , , , , , , - Immunity 2021 被引用: 118

  9. Distributed Multi-Energy Operation of Coupled Electricity, Heating, and Natural Gas Networks

    著者: , , , , , - IEEE Transactions on Sustainable Energy 2019 被引用: 366

  10. Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling

    著者: , , - Science China Life Sciences 2016 被引用: 96

  11. The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial

    著者: , , , , , , , , , , , , , , , , , , - Frontiers in Immunology 2023 被引用: 51

  12. The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner

    著者: , , , , , , , , - Nature Communications 2017 被引用: 189

  13. The Epidemiology of Monophasic Salmonella Typhimurium

    著者: , , , - Foodborne Pathogens and Disease 2019 被引用: 162

  14. A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liang Li, Peng Yu, Yong‐Tang Zheng, Diana Boraschi, Hongchang Li, Chunying Chen, Liming Wang, Yang Li, Yang Li, Yang Li - Nature Nanotechnology 2022 被引用: 118

  15. Air Pollution as a Risk Factor for Incident Chronic Obstructive Pulmonary Disease and Asthma. A 15-Year Population-Based Cohort Study

    著者: , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 被引用: 173

  16. ASC deglutathionylation is a checkpoint for NLRP3 inflammasome activation

    著者: , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2021 被引用: 78

  17. First‐line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - International Journal of Cancer 2022 被引用: 70

  18. The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors

    著者: , , , , , , , , , - Critical Reviews in Food Science and Nutrition 2014 被引用: 158

  19. Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2020 被引用: 108

  20. Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 129

  21. Antimicrobial Resistance inListeriaSpecies

    著者: , , , , , , - Microbiology Spectrum 2018 被引用: 105

  22. Berberine attenuates depressive-like behaviors by suppressing neuro-inflammation in stressed mice

    著者: , , , , , , - Brain Research Bulletin 2017 被引用: 91

  23. Pseudoneutrophil Cytokine Sponges Disrupt Myeloid Expansion and Tumor Trafficking to Improve Cancer Immunotherapy

    著者: , , , , , , , , , , - Nano Letters 2019 被引用: 84

  24. Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells

    著者: , , , , , , , , , , , , , - Immunity 2013 被引用: 248